J Korean Ophthalmol Soc > Volume 51(5); 2010 > Article
Journal of the Korean Ophthalmological Society 2010;51(5):774-778.
DOI: https://doi.org/10.3341/jkos.2010.51.5.774    Published online May 15, 2010.
Macular Hole Following Intravitreal Ranibizumab Injections for Choroidal Neovascularization.
Young Joon Jo, Kyoung Nam Kim, Jong Eun Lee, Jung Yeul Kim
1Department of Ophthalmology, Chungnam National University Hospital, Daejeon, Korea. kimjy@cnu.ac.kr
2Institute for Medical Sciences, Chungnam National University Research, Daejeon, Korea.
맥락막신생혈관이 있는 환자에서 루센티스 안내주사 후 발생한 황반원공
조영준1,2ㆍ김경남1ㆍ이종은1,2ㆍ김정열1,2
Department of Ophthalmology, Chungnam National University Hospital1, Daejeon, Korea Institute for Medical Sciences, Chungnam National University Research2, Daejeon, Korea
Abstract
PURPOSE
To report a case of macular hole following intravitreal ranibizumab injection in choroidal neovascularization associated with age-related macular degeneration. CASE SUMMARY: A 73-year-old man was referred for a sudden decline in vision in his right eye. The best corrected visual acuity was 0.15 in the right eye and 0.9 in the left eye. There was a choroidal neovascularization associated with subretinal hemorrhage in the right eye. Optical coherence tomogram (OCT) showed subretinal hemorrhage and pigment retinal epithelium detachment in the right eye. The patient received intravitreal ranibizumab injection. Four weeks after the initial treatment, the best corrected visual acuity of the right eye was improved to 0.3. The patient received a second intravitreal ranibizumab injection. Four weeks after the second injection, the patient presented with further decreased vision in his right eye, with a best corrected visual acuity of 0.02. Although the fundus examination was indistinct, OCT confirmed the presence of a full thickness macular hole. The patient received a third intravitreal ranibizumab injection. Four weeks after receiving the third injection, the patient underwent pars plana vitrectomy with internal limiting membrane peeling and fluid-gas exchange. Four months later, the macula hole was closed completely and visual acuity was 0.1. CONCLUSIONS: Although it is rare, intravitreal ranibizumab injection in the treatment of choroidal neovascularization secondary to age-related macular degeneration may cause complicated by a macular hole.
Key Words: Age related macular degeneration;Choroidal neovascularization;Macula hole;Ranibizumab


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next